2023 Vault Rankings
At a Glance
“Collegiate atmosphere, incredibly smart and kind employees, receptive upper management.”
“Kx's company culture and commitment to pay equity are two of the best things about the firm.”
“Relaxed atmosphere while delivering high quality work.”
“COVID has made it challenging to collaborate with our London colleagues outside of Zoom/Teams.”
“Rapid growth requires significant time investment to onboard new hires.”
“There are limited clients working at any point. It can be a little hard to not get pigeonholed.”
About Kx Advisors
Kx Advisors (previously operating as Kaiser Associates’ Healthcare Practice) has provided strategy consulting services to help healthcare executives achieve critical business growth goals for more than forty years. With a highly collaborative approach, they have developed pragmatic solutions for leading pharmaceutical, biotechnology, medical device, health IT, and diagnostics clients, with data-driven insights to give those clients the tools to compete and win across the healthcare industry.
Kx Advisors does this by conducting comprehensive primary research and data-driven analysis at all stages of the product lifecycle to inform the decision making of sales, marketing, and strategy executives. The Kx approach establishes the required fact base to vet critical decisions and brings together data from disparate sources to develop holistic strategies.
With offices in Washington DC, London, and Boston, Kx Advisors possesses the unique ability to generate global insights from physicians, thought leaders, patients, competitors, partners, regulators, suppliers, and payers.
1615 L Street, NW
13th Floor
Washington, DC, DC 20036
Phone: (202) 893-9200
Employer Type: Private
Managing Partner: Bob Serrano
Managing Partner: Dan O’Neill
Managing Partner: Jenna Riffell
Washington, DC
Boston, MA
London, UK
- Corporate Strategy and Franchise Planning
- Market Expansion and Forecasting
- Mergers and Acquisitions
- New Product Planning
- Pricing and Market Access
- Brand Planning and Launch Strategy
- Pharma and Biotech
- Medical Devices
- Diagnostics and Life Sciences
- Digital Health and Health IT
- Investors